This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Herb Greenberg

Editor, Herb Greenberg's Reality Check


Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk. He writes a daily blog for TheStreet's main free Web site and contributes to its Real Money's "Columnist Conversation" column as well as being a regular contributor for CNBC.


Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's business day programming and on CNBC.com. He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MarketWatch.


Prior to joining MarketWatch, Greenberg was senior columnist for TheStreet. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years as Fortune magazine's monthly "Against the Grain" columnist. Before that, he was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.


Greenberg holds a bachelor's degree in journalism from the University of Miami.


Herb Greenberg
By This Author:
Page 2 of 481
Alert

New Report Intrexon (XON): On the Verge of Something Very Big? (Reality Check $)

By Herb Greenberg

Synthetic biology is largely under-the-radar on Wall Street, but Intrexon may be on the verge of doing the kinds of deals that will put it front and center in a growth technology.

09:39AM 10/07/14

Alert

Tibco (TIBX): Is This Just the Opening Bid? (Reality Check $)

By Herb Greenberg

That $4.3 billion offer for the software company doesn't fully take into account its Spotfire business.

10:18AM 09/29/14

Herb Greenberg: Too Soon to Question GoPro's Earnings Quality?

By Herb Greenberg

Keep these points from its most recent quarter in mind.

10:31AM 09/26/14

Alert

Update Solar City (SCTY) — About that ‘Capped Call Transaction’ (Reality Check $)

By Herb Greenberg

With a debt deal that is way too complicated for its own good, clouds might be gathering on the horizon.

07:53AM 09/24/14

Why Playing the Patent-Fight Game Is Dangerous: Look at VirnetX

By Herb Greenberg

It's a crapshoot to play the patent game. Case in point: VirnetX

10:28AM 09/22/14

Alert

Alert: Carbo Ceramics (CRR) -- Company Issues Warning (Reality Check $)

By Herb Greenberg

The maker of materials for fracking is trying to put a positive spin on customers' shift to sand.

09:08AM 09/22/14

Alert

Update Tibco (TIBX) -- Earnings Miss, Story Doesn’t Change (Reality Check $)

By Herb Greenberg

Investors closely watching the situation at the enterprise software company shouldn't have been surprised by its disappointing results.

07:27AM 09/19/14

Greenberg: Stock Splits Are an Illusion So Don't Fall for Them

By Herb Greenberg

Stock splits might seem enticing, but they're nothing more than illusion promising more than they deliver.

09:34AM 09/18/14

Alert

Update Rackspace -- The Risk Rises (Reality Check $)

By Herb Greenberg

The company has stopped seeking a buyer, so it’s now a red flag on the Watch List.

12:28PM 09/17/14

Page 2 of 481

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,461.32 -153.49 -0.92%
S&P 500 1,927.11 -14.17 -0.73%
NASDAQ 4,382.8470 -36.6310 -0.83%

Brokerage Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs